About David

David is co-chair of Cooley’s global capital markets practice group. David practices general business and corporate law, representing both emerging and public companies in a variety of matters – including capital markets transactions, Securities and Exchange Commission (SEC) reporting and compliance, and corporate governance matters. He routinely represents issuers and investment banks in complex securities offerings – including initial public offerings (IPOs), follow-on offerings, 144A offerings, private investments in public equity (PIPEs), deSPACs and direct listings. His practice also includes company formations, venture capital financings and general corporate matters.

Passions

IPOs

Literature

Gator football

I believe corporate law can be as creative and disruptive as the clients I represent.

View full bio

Experience

View more

David always has creative solutions for the more complex and bespoke issues. He has a reputation for being the go-to for answers to the hardest questions.

Chambers USA, 2024

David is the only partner I would use for an IPO or financing, he is that good.

Chambers USA, 2025

Admissions and credentials

  • California
  • Not admitted to practice in Florida

Rankings and accolades

Chambers USA: Band 1: Capital Markets: Debt & Equity: Western United States – Nationwide (2019 – 2025)

Chambers USA: Band 1: Capital Markets: Debt & Equity – California (2019 – 2025)

Chambers USA: SPACs – Nationwide (2023)

The Legal 500 US: Leading Lawyer in Capital Markets: Equity Offerings (2020 – 2025)

Daily Journal: California Lawyer Attorneys of the Year Awards (2020)

IFLR1000 US: Lawyer of the Year – Capital Markets (2020)

Daily Journal: Top 100 Lawyers in California (2019 – 2020)

Law 360: Capital Markets MVP (2019)

The Legal 500 US: Next Generation Lawyer in Capital Markets: Equity (2019)

Daily Journal: Top 20 Under 40 (2014)

Memberships and affiliations

  • American Bar Association (ABA)
  • The Bar Association of San Francisco

Representative issuers:

Dave has represented companies/investment banks on capital market transactions involving issuers across industries, such as: 10X Genomics, 4D Molecular Therapeutics, Accelerate Diagnostics, Acutus Medical, Aerohive Networks, Alteryx, ALX Oncology, Ambarella, Amyris, Applied Molecular Transport, Anthera Pharmaceuticals, Apigee, Applied Molecular Transport, Annexon, Apptio, Arcadia Biosciences, Arcutis Biotherapeutics, Aridis Pharmaceuticals, ARMO BioSciences, Ascendis Pharma, ASLAN Pharmaceuticals, Atlassian, Athira Pharma, Audentes Therapeutics, Cision, Crinetics Pharmaceuticals, Dermira, DocuSign, Doximity, Dutch Bros., EHang, Eidos Therapeutics, Expensify, Fantex, FIGS, FireEye, Five Prime Therapeutics, Global Blood Therapeutics, Gossamer Bio, Graphite Bio, Gritstone Oncology, Guardant Health, Health Catalyst, HealthEquity, Hyperion Therapeutics, IGM Biosciences, Ignyta, Immune Design, Inhibrx, Invitae, Kinnate Biopharma, Kodiak Sciences, LinkedIn, Livongo Health, Lulu’s Fashion Lounge, Lyell Immunopharma, MINDBODY, Mobile Iron, NantKwest, Nanthealth, NerdWallet, New Relic, Olema Pharmaceuticals, Ooma, Opendoor Labs, Otonomy, Pliant Therapeutics, Principia Biopharma, PROCEPT BioRobotics, ProNai, ProQR Therapeutics, PROS Holdings, Rigel Pharmaceuticals, Qualtrics, Root, Sana Biotechnology, Satsuma Pharmaceuticals, Savara, Shockwave Medical, Sierra Oncology, Smart Share Global, Snap, Stitch Fix, Sutro Biopharma, Sweetgreen, Syndax Pharmaceuticals, Tableau Software, Taiwan Liposome Company, Treace Medical Concepts, Tricida, Trivascular, Twilio, Uber, Ventyx, ViewRay, Warby Parker, Wish, Xenon Pharmaceuticals, Xometry, Yelp, Zendesk, Zscaler, Zymeworks, Zynga.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.